XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenue $ 12,640 $ 9,427
Cost of Goods Sold 6,497 4,596
Gross Profit 6,143 4,831
Operating Expenses    
Research and development 4,044 2,013
Sales and marketing 615 24
General and administrative 26,332 17,485
Gain on the sale of assets (83) (1)
Depreciation and amortization 14,711 12,531
Impairment–Goodwill 62,385
Impairment–Intangibles 43,670
Total Operating Expenses 151,674 32,052
Net Operating Loss (145,531) (27,221)
Other Income (Expense)    
Interest expense (2,848) (11,309)
Loss on extinguishment of debt (4,602) (16)
Foreign currency transaction gain/(loss) 48 (74)
Interest income 2
Other income/(expense) (116) (1,369)
Total Other Expenses (7,518) (12,766)
Net Loss Before Income Taxes (153,049) (39,988)
Deferred Tax Benefit 2,906
Net Loss (153,049) (37,081)
Dividends on preferred stock (168)
Net loss available to common stockholders $ (153,217) $ (37,081)
Loss per common share:    
Basic and Diluted (in Dollars per share) $ (2.2) $ (0.82)
Weighted-average shares outstanding:    
Basic and Diluted (in Shares) 69,784 45,294